The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
Open accessAbstract
A biosynthetic antibody binding site, which incorporated the variable domains of anti-digoxin monoclonal antibody 26-10 in a single polypeptide chain (Mr = 26,354), was produced in Escherichia coli by protein engineering. This variable region fragment (Fv) analogue comprised the 26-10 heavy- and light-chain variable regions (VH and VL) connected by a 15-amino acid linker to form a single-chain Fv (sFv). The sFv was designed as a prolyl-VH-(linker)-VL sequence of 248 amino acids. A 744-base-pair DNA sequence corresponding to this sFv protein was derived by using an E. coli codon preference, and the sFv gene was assembled starting from synthetic oligonucleotides. The sFv polypeptide was expressed as a fusion protein in E. coli, using a leader derived from the trp LE sequence. The sFv protein was obtained by acid cleavage of the unique Asp-Pro peptide bond engineered at the junction of leader and sFv in the fusion protein [(leader)-Asp-Pro-VH-(linker)-VL]. After isolation and renaturation, folded sFv displayed specificity for digoxin and related cardiac glycosides similar to that of natural 26-10 Fab fragments. Binding between affinity-purified sFv and digoxin exhibited an association constant [Ka = (3.2 +/- 0.9) x 10(7) M-1] that was about a factor of 6 smaller than that found for 26-10 Fab fragments [Ka = (1.9 +/- 0.2) x 10(8) M-1] under the same buffer conditions, consisting of 0.01 M sodium acetate, pH 5.5/0.25 M urea.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Yanisch-Perron, C., Vieira, J., & Messing, J. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 15,041
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,578
Matsudaira, P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61070-1 · Cited by 4,950
Rapid analysis of amino acids using pre-column derivatization
Bidlingmeyer, B. A., Cohen, S. A., & Tarvin, T. L. (1984) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)85133-6 · Cited by 2,514
The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
Porter, R. R. (1959) · Biochemical Journal · doi:10.1042/bj0730119 · Cited by 2,308
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Cited by
Phage antibodies: filamentous phage displaying antibody variable domains
McCafferty, J., Griffiths, A. D., Winter, G., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,423
Fusion protein linkers: Property, design and functionality
Chen, X., Zaro, J. L., & Shen, W.-C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.039 · Cited by 2,056
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Eshhar, Z., Waks, T., Gross, G., & Schindler, D. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.720 · Cited by 1,658
Marks, J. D., Hoogenboom, H. R., Bonnert, T. P., McCafferty, J., Griffiths, A. D., & Winter, G. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90498-u · Cited by 1,603
Single-Chain Antigen-Binding Proteins
Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S.-M., Lee, T., Pope, S. H., Riordan, G. S., & Whitlow, M. (1988) · Science · doi:10.1126/science.3140379 · Cited by 1,502
Bispecific antibodies: a mechanistic review of the pipeline
Labrijn, A. F., Janmaat, M. L., Reichert, J. M., & Parren, P. W. H. I. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0028-1 · Cited by 1,303
Making antibody fragments using phage display libraries
Clackson, T., Hoogenboom, H. R., Griffiths, A. D., & Winter, G. (1991) · Nature · doi:10.1038/352624a0 · Cited by 1,203
Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.
Barbas, C. F., Kang, A. S., Lerner, R. A., & Benkovic, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.7978 · Cited by 1,183
In vitro selection and evolution of functional proteins by using ribosome display
Hanes, J., & Plückthun, A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4937 · Cited by 1,088
Production of antibodies in transgenic plants
Hiatt, A., Caffferkey, R., & Bowdish, K. (1989) · Nature · doi:10.1038/342076a0 · Cited by 1,059
Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., & Johnson, K. S. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-309 · Cited by 1,027
Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chiswell, D. J., Hudson, P., & Winter, G. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4133 · Cited by 1,020
Winter, G., & Milstein, C. (1991) · Nature · doi:10.1038/349293a0 · Cited by 945
Dugel, P. U., Koh, A., Ogura, Y., Jaffe, G. J., Schmidt-Erfurth, U., Brown, D. M., Gomes, A. V., Warburton, J., Weichselberger, A., & Holz, F. G. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.04.017 · Cited by 931
Anatomy of the antibody molecule
Padlan, E. A. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90001-9 · Cited by 896
"Diabodies": small bivalent and bispecific antibody fragments.
Holliger, P., Prospero, T., & Winter, G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6444 · Cited by 874
Therapeutic antibodies for autoimmunity and inflammation
Chan, A. C., & Carter, P. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2761 · Cited by 837
scFv Antibody: Principles and Clinical Application
Ahmad, Z. A., Yeap, S. K., Ali, A. M., Ho, W. Y., Alitheen, N. B. M., & Hamid, M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/980250 · Cited by 760
Sampath, T. K., Maliakal, J. C., Hauschka, P. V., Jones, W. K., Sasak, H., Tucker, R. F., White, K. H., Coughlin, J. E., Tucker, M. M., & Pang, R. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88709-4 · Cited by 678
Stability engineering of antibody single-chain Fv fragments
Wörn, A., & Plückthun, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4265 · Cited by 616
Alternative molecular formats and therapeutic applications for bispecific antibodies
Spiess, C., Zhai, Q., & Carter, P. J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.003 · Cited by 607
OP-1 cDNA encodes an osteogenic protein in the TGF-beta family.
Ozkaynak, E., Rueger, D. C., Drier, E. A., Corbett, C., Ridge, R. J., Sampath, T. K., & Oppermann, H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07376.x · Cited by 554
Self-citationSingle domain camel antibodies: current status
Muyldermans, S. (2001) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(01)00021-6 · Cited by 552
Finney, H. M., Lawson, A. D. G., Bebbington, C. R., & Weir, A. N. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2791 · Cited by 546
A bioactive designer cytokine for human hematopoietic progenitor cell expansion
Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P. G., Kallen, K.-J., Wollmer, A., Grötzinger, J., & Rose-John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 530
Structural Evidence for Induced Fit as a Mechanism for Antibody-Antigen Recognition
Rini, J. M., Schulze-Gahmen, U., & Wilson, I. A. (1992) · Science · doi:10.1126/science.1546293 · Cited by 527
Smant, G., Stokkermans, J. P. W. G., Yan, Y., de Boer, J. M., Baum, T. J., Wang, X., Hussey, R. S., Gommers, F. J., Henrissat, B., Davis, E. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4906 · Cited by 482
Human anti-self antibodies with high specificity from phage display libraries.
Griffiths, A. D., Malmqvist, M., Marks, J. D., Bye, J. M., Embleton, M. J., McCafferty, J., Baier, M., Holliger, K. P., Gorick, B. D., & Hughes-Jones, N. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05706.x · Cited by 478
A comparison of strategies to stabilize immunoglobulin Fv-fragments
Glockshuber, R., Malia, M., Pfitzinger, I., & Plueckthun, A. (1990) · Biochemistry · doi:10.1021/bi00458a002 · Cited by 473
From bench to bedside: the history and progress of CAR T cell therapy
Mitra, A., Barua, A., Huang, L., Ganguly, S., Feng, Q., & He, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188049 · Cited by 466
Sheets, M. D., Amersdorfer, P., Finnern, R., Sargent, P., Lindqvist, E., Schier, R., Hemingsen, G., Wong, C., Gerhart, J. C., & Marks, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6157 · Cited by 438
Hoogenboom, H. R., & Winter, G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90894-p · Cited by 429
Design and Use of a Phage Display Library
Pini, A., Viti, F., Santucci, A., Carnemolla, B., Zardi, L., Neri, P., & Neri, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21769 · Cited by 422
Kreitman, R. J., Wilson, W. H., White, J. D., Stetler-Stevenson, M., Jaffe, E. S., Giardina, S., Waldmann, T. A., & Pastan, I. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1622 · Cited by 420
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
Chaudhary, V. K., Queen, G., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., & Pastan, I. (1989) · Nature · doi:10.1038/339394a0 · Cited by 413
By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling
Marks, J. D., Griffiths, A. D., Malmqvist, M., Clackson, T. P., Bye, J. M., & Winter, G. (1992) · Nature Biotechnology · doi:10.1038/nbt0792-779 · Cited by 404
A Chemical Approach to Protein Design—Template‐Assembled Synthetic Proteins (TASP)
Mutter, M., & Vuilleumier, S. (1989) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198905353 · Cited by 400
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Koenig, P.-A., Das, H., Liu, H., Kümmerer, B. M., Gohr, F. N., Jenster, L.-M., Schiffelers, L. D. J., Tesfamariam, Y. M., Uchima, M., Wuerth, J. D., et al. (2021) · Science · doi:10.1126/science.abe6230 · Cited by 396
Kochenderfer, J. N., Yu, Z., Frasheri, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Blood · doi:10.1182/blood-2010-01-265041 · Cited by 391
Monoclonal Antibodies in Diagnosis and Therapy
Waldmann, T. A. (1991) · Science · doi:10.1126/science.2047874 · Cited by 385
Buchner, J., & Rudolph, R. (1991) · Nature Biotechnology · doi:10.1038/nbt0291-157 · Cited by 384
Recombinant Probes for Visualizing Endogenous Synaptic Proteins in Living Neurons
Gross, G. G., Junge, J. A., Mora, R. J., Kwon, H.-B., Olson, C. A., Takahashi, T. T., Liman, E. R., Ellis-Davies, G. C. R., McGee, A. W., Sabatini, B. L., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.017 · Cited by 357
A genetic analysis of crystal growth 1 1Edited by M. Gottesman
Brown, S., Sarikaya, M., & Johnson, E. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3682 · Cited by 355
In-vitro protein evolution by ribosome display and mRNA display
Lipovsek, D., & Plückthun, A. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.04.008 · Cited by 353
A guide to: generation and design of nanobodies
Muyldermans, S. (2021) · The FEBS Journal · doi:10.1111/febs.15515 · Cited by 352
Mack, M., Riethmüller, G., & Kufer, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7021 · Cited by 351
Antibody‐Conjugated Nanoparticles for Biomedical Applications
Arruebo, M., Valladares, M., & González-Fernández, Á. (2009) · Journal of Nanomaterials · doi:10.1155/2009/439389 · Cited by 331
Biophysical Properties of Human Antibody Variable Domains
Ewert, S., Huber, T., Honegger, A., & Plückthun, A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01237-8 · Cited by 330
New protein engineering approaches to multivalent and bispecific antibody fragments
Plückthun, A., & Pack, P. (1997) · Immunotechnology · doi:10.1016/s1380-2933(97)00067-5 · Cited by 322
Site-directed antibody immobilization techniques for immunosensors
Makaraviciute, A., & Ramanaviciene, A. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.06.060 · Cited by 316
Immunotoxins for targeted cancer therapy
Kreitman, R. J. (2006) · The AAPS Journal · doi:10.1208/aapsj080363 · Cited by 307
Development trends for therapeutic antibody fragments
Nelson, A. L., & Reichert, J. M. (2009) · Nature Biotechnology · doi:10.1038/nbt0409-331 · Cited by 305
Bispecific Antibodies: From Research to Clinical Application
Ma, J., Mo, Y., Tang, M., Shen, J., Qi, Y., Zhao, W., Huang, Y., Xu, Y., & Qian, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626616 · Cited by 305
Recombinant Toxins for Cancer Treatment
Pastan, I., & FitzGerald, D. (1991) · Science · doi:10.1126/science.1683495 · Cited by 299
Antibodies from phage antibody libraries
Bradbury, A. R. M., & Marks, J. D. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.04.007 · Cited by 296
Imaging proteins inside cells with fluorescent tags
Crivat, G., & Taraska, J. W. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.08.002 · Cited by 291
Röthlisberger, D., Honegger, A., & Plückthun, A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.01.053 · Cited by 289
Neri, D., Carnemolla, B., Nissim, A., Leprini, A., Querzè, G., Balza, E., Pini, A., Tarli, L., Halin, C., Neri, P., et al. (1997) · Nature Biotechnology · doi:10.1038/nbt1197-1271 · Cited by 282
Current progress in innovative engineered antibodies
Strohl, W. R. (2018) · Protein & Cell · doi:10.1007/s13238-017-0457-8 · Cited by 279
Biragyn, A., Tani, K., Grimm, M. C., Weeks, S., & Kwak, L. W. (1999) · Nature Biotechnology · doi:10.1038/6995 · Cited by 278
Design and application of diabodies, triabodies and tetrabodies for cancer targeting
Todorovska, A., Roovers, R. C., Dolezal, O., Kortt, A. A., Hoogenboom, H. R., & Hudson, P. J. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00342-2 · Cited by 272
Overexpression of Eag1 potassium channels in clinical tumours
Hemmerlein, B., Weseloh, R. M., Mello de Queiroz, F., Knötgen, H., Sánchez, A., Rubio, M. E., Martin, S., Schliephacke, T., Jenke, M., Heinz-Joachim-Radzun, et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-41 · Cited by 265
Antibody engineering: Comparison of bacterial, yeast, insect and mammalian expression systems
Verma, R., Boleti, E., & George, A. J. T. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00077-5 · Cited by 265
Selection of human antibody fragments by phage display
Lee, C. M. Y., Iorno, N., Sierro, F., & Christ, D. (2007) · Nature Protocols · doi:10.1038/nprot.2007.448 · Cited by 262
Applications of single-chain variable fragment antibodies in therapeutics and diagnostics
Weisser, N. E., & Hall, J. C. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.04.004 · Cited by 261
Novel immunotherapies in lymphoid malignancies
Batlevi, C. L., Matsuki, E., Brentjens, R. J., & Younes, A. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.187 · Cited by 260
David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments
Bates, A., & Power, C. A. (2019) · Antibodies · doi:10.3390/antib8020028 · Cited by 237
A chimeric human-cat fusion protein blocks cat-induced allergy
Zhu, D., Kepley, C. L., Zhang, K., Terada, T., Yamada, T., & Saxon, A. (2005) · Nature Medicine · doi:10.1038/nm1219 · Cited by 188
Bach, H., Mazor, Y., Shaky, S., Shoham-Lev, A., Berdichevsky, Y., Gutnick, D. L., & Benhar, I. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4914 · Cited by 178
“antibody variable domains connected by a ̄exible linker.(1,2) These antibody fragments can be produced”
Fully human therapeutic monoclonal antibodies.
Weiner, L. M. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000192105.24583.83 · Cited by 164
Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments
Sandomenico, A., Sivaccumar, J. P., & Ruvo, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176324 · Cited by 134
“These linkers are widely used to keep the carboxy terminus of one variable domain and the amino terminus of the other at a distance that favors the correct folding and the formation of the antigen-binding site while minimizing, at the same time, the oligomerization [25,26].”
BackgroundLe Gall, F., Kipriyanov, S. M., Moldenhauer, G., & Little, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00713-9 · Cited by 128
KORTT, A. A., MALBY, R. L., CALDWELL, J. B., GRUEN, L. C., IVANCIC, N., LAWRENCE, M. C., HOWLETT, G. J., WEBSTER, R. G., HUDSON, P. J., & COLMAN, P. M. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18724.x · Cited by 128
Pechan, P., Rubin, H., Lukason, M., Ardinger, J., DuFresne, E., Hauswirth, W. W., Wadsworth, S. C., & Scaria, A. (2009) · Gene Therapy · doi:10.1038/gt.2008.115 · Cited by 104
AbDb: antibody structure database-a database of PDB-derived antibody structures
Ferdous, S., & Martin, A. C. R. (2018) · Database · doi:10.1093/database/bay040 · Cited by 87
“scFvs are fused VH (variable heavy) and VL (variable light) domains with a peptide linker [24].”
BackgroundSonoda, H., Kumada, Y., Katsuda, T., & Yamaji, H. (2011) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2010.12.015 · Cited by 45
Weatherill, E. E., Cain, K. L., Heywood, S. P., Compson, J. E., Heads, J. T., Adams, R., & Humphreys, D. P. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzs021 · Cited by 42
ScFv‐Decorated PEG‐PLA‐Based Nanoparticles for Enhanced siRNA Delivery to Her2+ Breast Cancer
Dou, S., Yang, X., Xiong, M., Sun, C., Yao, Y., Zhu, Y., & Wang, J. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400037 · Cited by 39
Sonoda, H., Kumada, Y., Katsuda, T., & Yamaji, H. (2010) · Protein Expression and Purification · doi:10.1016/j.pep.2009.11.003 · Cited by 36
Liu, C., Kobashigawa, Y., Yamauchi, S., Toyota, Y., Teramoto, M., Ikeguchi, Y., Fukuda, N., Sato, T., Sato, Y., Kimura, H., et al. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz059 · Cited by 15
Noguchi, T., Nishida, Y., Takizawa, K., Cui, Y., Tsutsumi, K., Hamada, T., & Nishi, Y. (2017) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.11.014 · Cited by 12
Liu, C., Kobashigawa, Y., Yamauchi, S., Fukuda, N., Sato, T., Masuda, T., Ohtsuki, S., & Morioka, H. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa042 · Cited by 6
Peng, W., Bao, Q., Jia, R., & He, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974014 · Cited by 4
Metadata
- Authors
- Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotný, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., & Crea, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1988-08
- Volume
- 85
- Issue
- 16
- Pages
- 5879-5883
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2156037313
- Cited by
- 1,593
- References
- 31
- FWCI
- 32.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.